| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B MYH7 ABCA13 DDX1 ABCB1 ABCB4 DDX50 DDX18 RECQL5 HSPA2 DYNC1H1 DNAH3 ABCB5 DNAH12 DDX3Y HSP90AB2P ATP2A1 | 3.99e-05 | 441 | 248 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B MYH7 ABCA13 KIF4A DDX1 ABCB1 ABCB4 DDX50 DDX18 RECQL5 HSPA2 DYNC1H1 DNAH3 SLC27A6 ABCB5 DNAH12 DDX3Y KIF4B HSP90AB2P ATP2A1 | 8.89e-05 | 614 | 248 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B MYH7 MARK1 OBSCN KIF4A EML2 RABGAP1 ACTN2 PXK NDC80 DLG1 TTLL1 PLEKHH2 WASF1 HSPA2 MTUS2 AGTPBP1 AMPD1 NRCAM CAPN3 REEP3 KPTN RMDN3 P4HB CLMN TLN1 APPL1 KIF4B EPB41L2 | 1.07e-04 | 1099 | 248 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | adenylylsulfate kinase activity | 1.54e-04 | 2 | 248 | 2 | GO:0004020 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase (ATP) activity | 1.54e-04 | 2 | 248 | 2 | GO:0004781 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase activity | 1.54e-04 | 2 | 248 | 2 | GO:0004779 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.33e-04 | 70 | 248 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 4.21e-04 | 78 | 248 | 6 | GO:0051536 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 4.57e-04 | 3 | 248 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | metal cluster binding | 5.87e-04 | 83 | 248 | 6 | GO:0051540 | |
| GeneOntologyMolecularFunction | titin binding | 6.23e-04 | 14 | 248 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.86e-04 | 118 | 248 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 9.07e-04 | 4 | 248 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | protein antigen binding | 9.40e-04 | 16 | 248 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | carbon-sulfur lyase activity | 9.40e-04 | 16 | 248 | 3 | GO:0016846 | |
| GeneOntologyMolecularFunction | 3'-5'-DNA exonuclease activity | 9.40e-04 | 16 | 248 | 3 | GO:0008296 | |
| Domain | aa-tRNA-synth_II | 7.29e-05 | 18 | 242 | 4 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 7.29e-05 | 18 | 242 | 4 | PS50862 | |
| Domain | Sulfurylase_cat_dom | 1.67e-04 | 2 | 242 | 2 | IPR024951 | |
| Domain | PUA_2 | 1.67e-04 | 2 | 242 | 2 | PF14306 | |
| Domain | Sulphate_adenylyltransferase | 1.67e-04 | 2 | 242 | 2 | IPR002650 | |
| Domain | ATP-sulfurylase | 1.67e-04 | 2 | 242 | 2 | PF01747 | |
| Domain | APS_kinase | 1.67e-04 | 2 | 242 | 2 | IPR002891 | |
| Domain | ATP-Sase_PUA-like_dom | 1.67e-04 | 2 | 242 | 2 | IPR025980 | |
| Domain | SPRY | 2.21e-04 | 94 | 242 | 7 | PF00622 | |
| Domain | SPRY_dom | 2.21e-04 | 94 | 242 | 7 | IPR003877 | |
| Domain | B30.2/SPRY | 2.36e-04 | 95 | 242 | 7 | IPR001870 | |
| Domain | B302_SPRY | 2.36e-04 | 95 | 242 | 7 | PS50188 | |
| Domain | TPR-like_helical_dom | IFT140 IFT172 P4HA3 TRRAP SMYD4 TTC13 CFAP70 FKBP5 SMG6 RMDN3 TTC17 | 2.40e-04 | 233 | 242 | 11 | IPR011990 |
| Domain | P-loop_NTPase | KIF21B MYH7 ABCA13 KIF4A DDX1 ABCB1 ABCB4 DAP3 DDX50 DDX18 RECQL5 DLG1 DYNC1H1 AGAP1 AGAP3 DNAH3 ABCB5 CHST1 PAPSS2 PAPSS1 DNAH12 GNA13 DDX3Y KIF4B | 2.86e-04 | 848 | 242 | 24 | IPR027417 |
| Domain | aa-tRNA-synt_IIb | 3.28e-04 | 11 | 242 | 3 | IPR002314 | |
| Domain | - | 3.28e-04 | 11 | 242 | 3 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 3.28e-04 | 11 | 242 | 3 | PF00587 | |
| Domain | ConA-like_dom | CMYA5 DDX1 RYR3 SLIT2 HERC1 TRIM60 LAMA2 COL5A3 ASH2L TRIM62 | 5.94e-04 | 219 | 242 | 10 | IPR013320 |
| Domain | ATPase_dyneun-rel_AAA | 7.04e-04 | 14 | 242 | 3 | IPR011704 | |
| Domain | Anticodon-bd | 7.04e-04 | 14 | 242 | 3 | IPR004154 | |
| Domain | AAA_8 | 7.04e-04 | 14 | 242 | 3 | PF12780 | |
| Domain | AAA_5 | 7.04e-04 | 14 | 242 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.04e-04 | 14 | 242 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 7.04e-04 | 14 | 242 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.04e-04 | 14 | 242 | 3 | PF08393 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | OBSCN RABGAP1 PDE10A BCR ARMC2 TRRAP EPS15L1 ZNF638 SLC9A7 AFF1 DLG1 HECTD1 FKBP5 RIC1 AGAP1 SMG6 AGAP3 NEDD4L FOLH1 MAN1C1 ZNF875 PIK3R3 PCDH11Y HECTD4 SYT2 GTF2IRD1 REEP3 NCS1 HIVEP3 ERGIC1 EVA1C ZNF532 CLMN LPCAT3 ZFHX3 TTC17 EIF2AK4 ZNF84 KAT6B PCCA PRKX | 1.50e-13 | 1489 | 250 | 41 | 28611215 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACO2 GARS1 DDX1 PTPN1 S100P DDX18 DLD HSPA2 TARS1 DYNC1H1 SFPQ APEX1 COL5A3 DPP3 PAPSS2 EPG5 HIVEP3 RMDN3 PDIA6 P4HB NANS TLN1 ZFHX3 ATP2A1 PCCA RPL3 ALG13 | 4.37e-11 | 807 | 250 | 27 | 30575818 |
| Pubmed | MARK1 ACO2 ZNF185 NARS1 ACTN2 BCR ELFN2 DDX1 EPS15L1 NUFIP2 DLD DLG1 WASF1 HSPA2 MTUS2 TARS1 DYNC1H1 AGTPBP1 AGAP3 CUL3 DMXL2 SFPQ NEDD4L NRCAM PDIA6 TENM4 P4HB CLMN TLN1 EIF4G2 PLXNA4 DDX3Y TAF15 RPL3 EPB41L2 | 2.75e-10 | 1431 | 250 | 35 | 37142655 | |
| Pubmed | MYH7 PRELID1 ACO2 GARS1 ACTN2 PDE10A DDX1 ABCB1 ABCB4 DAP3 DDX50 SCN9A DLD DLG1 TTLL1 HSPA2 SFPQ PCDHGB7 ABCB5 ANKRD26 GRIA4 PDIA6 TBC1D31 P4HB GNA13 SEC23IP SUPT16H PLXNA4 TAF15 EIF2AK4 ZNF84 ATP2A1 RPL3 PCDHGA8 SLC4A11 | 3.36e-10 | 1442 | 250 | 35 | 35575683 | |
| Pubmed | KIF4A PTPN1 EPS15L1 DDX50 DDX18 ZNF638 PKP2 DLG1 WASF1 TARS1 DYNC1H1 AGAP1 AGAP3 ANKRD26 AP4E1 ARFGAP2 IGF2BP1 ZBED6 SEC23IP ZFHX3 TAF15 AP4M1 PCCA RPL3 EPB41L2 | 5.35e-10 | 777 | 250 | 25 | 35844135 | |
| Pubmed | MYH7 OBSCN ACTN2 CMYA5 AGTPBP1 AMPD1 DMXL2 SFPQ CAPN3 ANKRD26 LAMA2 ASH2L P4HB CLMN TLN1 SUPT16H EIF4G2 APPL1 ATP2A1 | 4.47e-09 | 497 | 250 | 19 | 23414517 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MRPL44 NARS1 RBM25 HECTD1 TARS1 CUL3 SFPQ POLE HAT1 ACAD10 NOL9 PAPSS2 PAPSS1 IGF2BP1 LPCAT3 SUPT16H EIF4G2 | 6.30e-09 | 400 | 250 | 17 | 35013556 |
| Pubmed | KIF21B KIF4A BCR EPS15L1 NUFIP2 DLG1 WASF1 DYNC1H1 SMG6 CUL3 DMXL2 SFPQ NEDD4L NRCAM HECTD4 NSD1 GRIA4 NOL9 SLC7A3 SEC23IP SUPT16H APPL1 KIF4B TAF15 CDH11 EPB41L2 | 9.07e-09 | 963 | 250 | 26 | 28671696 | |
| Pubmed | NARS1 KIF4A TRRAP URB1 RBM25 DDX18 NUFIP2 ZNF638 DLD HECTD1 HSPA2 DYNC1H1 SFPQ POLE NSD1 NOL9 P4HB TLN1 TAF15 RPL3 EPB41L2 | 1.39e-08 | 653 | 250 | 21 | 22586326 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GARS1 NARS1 RABGAP1 CMYA5 DDX1 EPS15L1 DLD ANKMY2 HERC1 HECTD1 STK24 FKBP5 TARS1 DYNC1H1 CUL3 APEX1 HAT1 DPP3 PAPSS2 PAPSS1 NCS1 PDIA6 P4HB NANS TLN1 SEC23IP SUPT16H NCOA7 APPL1 HSP90AB2P RPL3 EPB41L2 | 2.14e-08 | 1455 | 250 | 32 | 22863883 |
| Pubmed | MRPL44 DAP3 PTPN1 URB1 DDX18 DLD DLG1 TTC13 HSPA2 FKBP5 TARS1 AGTPBP1 DMXL2 POLE PIK3R3 ANKRD26 FNDC3A NOL9 TBC1D8 PDIA6 TBC1D31 P4HB CLMN DNAJC15 TLN1 SSX2IP SUPT16H EIF4G2 TTC17 TAF15 RPL3 EPB41L2 | 3.54e-08 | 1487 | 250 | 32 | 33957083 | |
| Pubmed | ABCA13 MARK1 IFT172 DDX50 HECTD1 HSPA2 STK24 AGTPBP1 SMG6 SFPQ NRCAM RBL1 HAT1 COL5A3 IGF2BP1 P4HB IGSF1 RPL3 | 4.24e-08 | 513 | 250 | 18 | 25798074 | |
| Pubmed | IFT140 PSD BACH2 BCR TRRAP SLIT2 DAP3 RBM25 DDX18 GRAP2 PKP2 SPOP AGTPBP1 AGAP3 RBL1 PIK3R3 L1TD1 RMDN3 CCNB3 SSX2IP SUPT16H ZFHX3 KAT6B PCCA SLC4A11 TCTN2 ALG13 | 4.45e-08 | 1116 | 250 | 27 | 31753913 | |
| Pubmed | IFT172 DDX1 DDX18 HECTD1 HSPA2 TARS1 DYNC1H1 AGAP3 SFPQ HAT1 IGF2BP1 PDIA6 P4HB TLN1 SEC23IP SUPT16H EIF4G2 APPL1 RPL3 EPB41L2 | 4.71e-08 | 638 | 250 | 20 | 33239621 | |
| Pubmed | MAN2A1 ACO2 GARS1 NARS1 RETSAT PTPN1 DDX18 HEPHL1 DYNC1H1 SFPQ APEX1 PARP14 ASH2L ERGIC1 IGF2BP1 PDIA6 P4HB TLN1 SUPT16H TAF15 RPL3 | 5.88e-08 | 711 | 250 | 21 | 33022573 | |
| Pubmed | MARK1 ACO2 RABGAP1 BCR ELFN2 PTPN1 EPS15L1 NUFIP2 DLD DLG1 WASF1 HSPA2 AGAP3 DMXL2 SFPQ NEDD4L NRCAM GRIA4 NCS1 ARFGAP2 TENM4 AKR7L P4HB EIF4G2 APPL1 PCCA EPB41L2 | 6.71e-08 | 1139 | 250 | 27 | 36417873 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MARK1 ACO2 MRPL44 TRRAP DDX1 DAP3 RBM25 DDX50 DDX18 PAN2 ZNF638 DYNC1H1 DMXL2 SFPQ NEDD4L AGPAT2 HECTD4 APEX1 GTF2IRD1 IGF2BP1 PDIA6 ZNF532 P4HB SUPT16H DDX3Y TAF15 | 9.17e-08 | 1082 | 250 | 26 | 38697112 |
| Pubmed | MARK1 OBSCN WWC2 URB1 SCML2 DDX50 ALDH1L2 PAN2 ZNF638 AFF1 DLG1 HERC1 STK24 AKT3 SFPQ SPOPL NSD1 NOL9 ASH2L SLC7A3 TBC1D31 P4HB CLMN EIF4G2 DDX3Y EIF2AK4 | 9.50e-08 | 1084 | 250 | 26 | 11544199 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | IFT140 IFT172 GARS1 ITGAV BCR DDX1 SLIT2 EPS15L1 NUFIP2 PAN2 ZNF638 ANKMY2 WASF1 DYNC1H1 AGAP1 AGAP3 CUL3 RBL1 AGPAT2 REEP3 ERGIC1 P4HB NANS LPCAT3 SEC23IP SUPT16H APPL1 HSP90AB2P TCTN2 | 1.08e-07 | 1321 | 250 | 29 | 27173435 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACO2 GARS1 ZNF185 NARS1 KIF4A TRRAP DDX1 URB1 DDX50 DDX18 RECQL5 ZNF638 PKP2 TARS1 DYNC1H1 SFPQ POLE NOL9 PAPSS2 MEMO1 PDIA6 P4HB NANS TLN1 SUPT16H EIF4G2 HSP90AB2P RPL3 EPB41L2 | 1.78e-07 | 1353 | 250 | 29 | 29467282 |
| Pubmed | ACO2 NARS1 CMYA5 DDX1 DDX50 TARS1 AGAP3 CUL3 SFPQ NOL9 ZNF251 IGF2BP1 ZSCAN22 SEC23IP EIF4G2 DDX3Y | 2.10e-07 | 451 | 250 | 16 | 36168627 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | BACH2 ZNF185 BCR EPS15L1 NDC80 DLD HSPA2 DYNC1H1 CUL3 ANKRD26 AP4E1 ARFGAP2 TBC1D31 NANS TLN1 SSX2IP EIF4G2 SNX18 UNK TTC17 AP4M1 PCCA | 2.90e-07 | 853 | 250 | 22 | 28718761 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ZNF185 RETSAT TRRAP EPS15L1 SLC9A7 DLG1 HERC1 RBL1 CASQ2 TBC1D8 ERGIC1 EVA1C P4HB LPCAT3 SEC23IP PTCD2 NCOA7 TTC17 SLAMF7 RNF182 | 3.18e-07 | 719 | 250 | 20 | 35337019 |
| Pubmed | 3.67e-07 | 3 | 250 | 3 | 9542318 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | SMYD4 RBM25 DLG1 HECTD1 WASF1 STK24 AGAP1 SMG6 NEDD4L REEP3 ASH2L TENM4 P4HB PTCD2 ZFHX3 KAT6B EPB41L2 | 4.20e-07 | 536 | 250 | 17 | 15840001 |
| Pubmed | SMYD4 RBM25 DLG1 HECTD1 WASF1 STK24 AGAP1 SMG6 NEDD4L REEP3 ASH2L TENM4 P4HB PTCD2 ZFHX3 KAT6B EPB41L2 | 4.42e-07 | 538 | 250 | 17 | 10512203 | |
| Pubmed | MAN2A1 KIF4A RDH13 TRRAP URB1 SCML2 DDX50 RECQL5 NUFIP2 DLG1 AGAP1 SMG6 AGAP3 AGPAT2 NSD1 APEX1 NOL9 ASH2L ERGIC1 RMDN3 PDIA6 P4HB ZBED6 TLN1 EIF4G2 UNK ZFHX3 TAF15 HSP90AB2P EPB41L2 | 4.46e-07 | 1497 | 250 | 30 | 31527615 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MRPL44 DDX1 DAP3 URB1 RBM25 DDX50 DDX18 NUFIP2 ZNF638 DYNC1H1 SFPQ APEX1 IGF2BP1 P4HB SUPT16H EIF4G2 PTCD2 UNK TAF15 RPL3 ALG13 | 4.73e-07 | 807 | 250 | 21 | 22681889 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ACO2 GARS1 NARS1 DDX1 DAP3 RBM25 DDX18 DLD TARS1 PAPSS1 IGF2BP1 PDIA6 P4HB NANS TLN1 SUPT16H EIF4G2 EPB41L2 | 5.05e-07 | 607 | 250 | 18 | 39147351 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | DDX1 RBM25 DDX18 DLD HECTD1 DYNC1H1 AGTPBP1 L1TD1 HAT1 SEC23IP TAF15 EPB41L2 | 6.70e-07 | 269 | 250 | 12 | 29511261 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRRAP WWC2 EPS15L1 RBM25 SCML2 ZNF638 AFF1 DLG1 FKBP5 AGTPBP1 CUL3 EXO5 GTF2IRD1 PDIA6 EIF4G2 UNK APPL1 SNAPC4 KAT6B EPB41L2 | 9.97e-07 | 774 | 250 | 20 | 15302935 |
| Pubmed | NARS1 PTPN1 EPS15L1 RBM25 NUFIP2 PKP2 DLG1 TARS1 DYNC1H1 ANKRD26 FNDC3A TBC1D8 ARFGAP2 PDIA6 TLN1 SEC23IP EIF4G2 RPL3 EPB41L2 | 1.08e-06 | 708 | 250 | 19 | 39231216 | |
| Pubmed | 1.31e-06 | 76 | 250 | 7 | 36560452 | ||
| Pubmed | BCR DDX1 SMYD4 ZNF638 DLG1 RIC1 CUL3 DMXL2 RBL1 POLE NOL9 PAPSS2 ASH2L ARFGAP2 PDIA6 RHPN2 EIF2AK4 RPL3 | 1.34e-06 | 650 | 250 | 18 | 38777146 | |
| Pubmed | ACO2 GARS1 NARS1 KIF4A DDX1 S100P RBM25 DDX18 NUFIP2 PKP2 DLD AFF1 DLG1 HECTD1 FKBP5 TARS1 DYNC1H1 SFPQ APEX1 PAPSS1 P4HB TLN1 EIF4G2 DDX3Y TAF15 RPL3 | 1.34e-06 | 1247 | 250 | 26 | 27684187 | |
| Pubmed | PI4K2B MAN2A1 KIF4A RETSAT BCR DDX1 EPS15L1 DDX50 NDC80 DDX18 NUFIP2 HSPA2 FKBP5 DYNC1H1 CUL3 SLC11A2 FNDC3A NOL9 PARP14 ERGIC1 GNA13 LPCAT3 EIF4G2 DDX3Y CTSW | 1.36e-06 | 1168 | 250 | 25 | 19946888 | |
| Pubmed | 1.46e-06 | 4 | 250 | 3 | 28125646 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | IFT172 SLIT2 NUFIP2 SCN9A DLD PLG STK24 MTUS2 ACAD10 PREX2 TENM4 CLMN LPA UNK RPL3 | 2.15e-06 | 475 | 250 | 15 | 31040226 |
| Pubmed | IFT172 NARS1 CMYA5 RYR3 EPS15L1 DDX18 DLG1 HECTD1 HSPA2 MTUS2 TARS1 DYNC1H1 AGTPBP1 AGAP1 AGAP3 DMXL2 NRCAM FOLH1 HECTD4 ZNF251 ZNF532 SEC23IP EIF4G2 APPL1 TTC17 ZNF84 | 2.32e-06 | 1285 | 250 | 26 | 35914814 | |
| Pubmed | MYH7 KIF4A P4HA3 BCR TRRAP DDX18 NUFIP2 ZNF638 PLEKHH2 DYNC1H1 CUL3 SFPQ RBL1 APEX1 FNDC3A NOL9 ESYT3 ARFGAP2 P4HB | 2.70e-06 | 754 | 250 | 19 | 35906200 | |
| Pubmed | ZNF185 ITGAV DDX1 PTPN1 RBM25 DLG1 HSPA2 DYNC1H1 SFPQ SLC27A6 PDIA6 TLN1 SUPT16H DDX3Y RPL3 | 2.98e-06 | 488 | 250 | 15 | 31324722 | |
| Pubmed | 3.34e-06 | 15 | 250 | 4 | 24090483 | ||
| Pubmed | NOP132 is required for proper nucleolus localization of DEAD-box RNA helicase DDX47. | 3.63e-06 | 5 | 250 | 3 | 16963496 | |
| Pubmed | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. | 3.63e-06 | 5 | 250 | 3 | 22632832 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | PTPN1 DDX50 NUFIP2 PKP2 DLD FNDC3A RMDN3 IGF2BP1 P4HB CLMN TLN1 RPL3 EPB41L2 | 3.80e-06 | 375 | 250 | 13 | 32788342 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACO2 MRPL44 GARS1 RDH13 RABGAP1 DAP3 PTPN1 DDX50 NDC80 ALDH1L2 DDX18 ANKMY2 TTC13 HERC1 SMG6 SFPQ POLE FNDC3A NOL9 RMDN3 IGF2BP1 CLMN SSX2IP SEC23IP SUPT16H TTC17 RPL3 ALG13 | 4.10e-06 | 1496 | 250 | 28 | 32877691 |
| Pubmed | MYH7 PRELID1 HECTD1 DYNC1H1 CUL3 DMXL2 ABCB5 AP4E1 PDIA6 TLN1 RPL3 CDH11 | 4.33e-06 | 322 | 250 | 12 | 26514267 | |
| Pubmed | MARK1 DDX1 SLIT2 PTPN1 EPS15L1 NDC80 PKP2 TTC13 FKBP5 TARS1 ERGIC1 ARFGAP2 PDIA6 UBE2T P4HB SEC23IP EIF4G2 UNK APPL1 TTC17 AP4M1 EPB41L2 | 4.37e-06 | 1007 | 250 | 22 | 34597346 | |
| Pubmed | NARS1 KIF4A RABGAP1 TRRAP DDX1 S100P RBM25 DDX18 FKBP5 TARS1 CUL3 SFPQ POLE APEX1 HAT1 PAPSS1 UBE2T ZNF532 NANS SUPT16H EIF4G2 TAF15 | 4.88e-06 | 1014 | 250 | 22 | 32416067 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACO2 MRPL44 GARS1 CMYA5 DDX1 DAP3 PTPN1 URB1 RBM25 DDX50 DDX18 DLD TARS1 DYNC1H1 SFPQ POLE HAT1 NOL9 IGF2BP1 PDIA6 P4HB TLN1 SEC23IP SUPT16H EIF4G2 RPL3 EPB41L2 | 4.94e-06 | 1425 | 250 | 27 | 30948266 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ACO2 GARS1 NARS1 DDX1 DAP3 DDX50 NUFIP2 HSPA2 TARS1 DYNC1H1 SFPQ HAT1 IGF2BP1 PDIA6 P4HB SUPT16H HSP90AB2P RPL3 | 4.94e-06 | 714 | 250 | 18 | 28302793 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TRRAP DDX1 ABCB1 SLIT2 URB1 RBM25 DDX50 DDX18 ZNF638 TARS1 DYNC1H1 SFPQ NEDD4L IGF2BP1 PDIA6 P4HB GNA13 TLN1 SUPT16H TAF15 RPL3 EPB41L2 | 5.70e-06 | 1024 | 250 | 22 | 24711643 |
| Pubmed | MRPL44 GARS1 DDX1 ALDH1L2 DDX18 NUFIP2 DYNC1H1 CUL3 AMPD1 SFPQ POLE HAT1 IGF2BP1 PDIA6 P4HB TAF15 HSP90AB2P RPL3 | 6.08e-06 | 725 | 250 | 18 | 27025967 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | KIF4A DDX1 EPS15L1 RBM25 SCML2 DDX50 DDX18 RECQL5 NUFIP2 ZNF638 HSPA2 SFPQ NSD1 APEX1 IGF2BP1 SUPT16H EIF4G2 DDX3Y TAF15 ATP2A1 PCCA | 6.49e-06 | 954 | 250 | 21 | 36373674 |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 6.76e-06 | 97 | 250 | 7 | 37151849 | |
| Pubmed | KIF4A BCR PTPN1 SCML2 NUFIP2 ZNF638 DLG1 TTC13 HECTD1 FKBP5 AGTPBP1 FNDC3A REEP3 TBC1D31 CLMN SEC23IP UNK TTC17 | 7.06e-06 | 733 | 250 | 18 | 34672954 | |
| Pubmed | Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow. | 7.22e-06 | 6 | 250 | 3 | 27250503 | |
| Pubmed | EML2 RDH13 RBM25 NUFIP2 NKX6-1 DMXL2 SFPQ AGPAT2 PAPSS2 PAPSS1 MEMO1 ARFGAP2 P4HB RPL3 | 7.89e-06 | 464 | 250 | 14 | 32457219 | |
| Pubmed | 8.83e-06 | 101 | 250 | 7 | 10997877 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 GARS1 NARS1 DDX1 DAP3 NUFIP2 HSPA2 FKBP5 TARS1 DYNC1H1 CUL3 SFPQ APEX1 HAT1 NOL9 ASH2L IGF2BP1 PDIA6 P4HB TLN1 SUPT16H RPL3 EPB41L2 | 1.09e-05 | 1149 | 250 | 23 | 35446349 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | GARS1 KIF4A DDX1 PTPN1 URB1 RBM25 DDX50 DDX18 NUFIP2 ZNF638 SFPQ APEX1 HAT1 NOL9 PDIA6 P4HB SUPT16H TAF15 HSP90AB2P PCCA RPL3 | 1.12e-05 | 989 | 250 | 21 | 36424410 |
| Pubmed | ACO2 RETSAT BCR SLIT2 PTPN1 ALDH1L2 DDX18 STK24 DYNC1H1 AGAP1 AGAP3 HAT1 FNDC3A NOL9 RMDN3 CLMN DDX3Y | 1.13e-05 | 686 | 250 | 17 | 28380382 | |
| Pubmed | DDX1 ABCB1 URB1 TARS1 DYNC1H1 SFPQ NOL9 IGF2BP1 PDIA6 TLN1 SEC23IP PCCA RPL3 EPB41L2 | 1.27e-05 | 484 | 250 | 14 | 31995728 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GARS1 NARS1 KIF4A RDH13 DDX1 DAP3 DDX18 ZNF638 HECTD1 TARS1 DYNC1H1 SFPQ NEDD4L APEX1 PAPSS2 MEMO1 IGF2BP1 PDIA6 P4HB DNAJC15 TLN1 SUPT16H EIF4G2 HSP90AB2P RPL3 EPB41L2 | 1.27e-05 | 1415 | 250 | 26 | 28515276 |
| Pubmed | MRPL44 GARS1 BCR TRRAP DDX1 DAP3 ZNF638 DLD ANKMY2 HECTD1 HSPA2 FKBP5 TARS1 CUL3 SFPQ HAT1 ASH2L IGF2BP1 PDIA6 P4HB SUPT16H EIF4G2 DDX3Y HSP90AB2P RPL3 | 1.38e-05 | 1335 | 250 | 25 | 29229926 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GARS1 RDH13 DDX1 PTPN1 URB1 DLD HECTD1 HSPA2 FKBP5 TARS1 DYNC1H1 CUL3 SFPQ POLE HAT1 NOL9 ERGIC1 IGF2BP1 PDIA6 P4HB DDX3Y TAF15 HSP90AB2P RPL3 | 1.51e-05 | 1257 | 250 | 24 | 37317656 |
| Pubmed | GARS1 DDX1 NUFIP2 TARS1 SFPQ APEX1 ASH2L P4HB TLN1 SEC23IP SUPT16H TAF15 HSP90AB2P RPL3 | 1.59e-05 | 494 | 250 | 14 | 26831064 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | KIF4A EPS15L1 SCML2 DDX50 NUFIP2 ZNF638 DLD SFPQ ANKRD26 IGF2BP1 PDIA6 CLMN TLN1 SEC23IP EIF4G2 NCOA7 TAF15 PCCA RPL3 EPB41L2 | 1.61e-05 | 934 | 250 | 20 | 33916271 |
| Pubmed | Genetic variations strongly influence phenotypic outcome in the mouse retina. | 1.99e-05 | 46 | 250 | 5 | 21779340 | |
| Pubmed | 2.00e-05 | 8 | 250 | 3 | 11784029 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH7 MRPL44 KIF4A EML2 CMYA5 TRRAP DAP3 RBM25 SPOP HERC1 STK24 TARS1 DYNC1H1 POLE PAPSS2 KPTN RMDN3 IGF2BP1 PDIA6 RHPN2 P4HB EIF4G2 RPL3 EPB41L2 | 2.12e-05 | 1284 | 250 | 24 | 17353931 |
| Pubmed | ACO2 OBSCN ACTN2 CMYA5 DLD DYNC1H1 SFPQ LAMA2 CASQ2 ACAD10 PCCA | 3.13e-05 | 331 | 250 | 11 | 29199018 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | KIF4A TRRAP DDX1 SCML2 DDX50 DDX18 ZNF638 ASH2L IGF2BP1 SUPT16H SNX18 EPB41L2 | 3.22e-05 | 394 | 250 | 12 | 27248496 |
| Pubmed | KIF21B IFT140 BCR PAN2 AGAP1 SMG6 CUL3 HECTD4 FNDC3A ZNF532 UNK EIF2AK4 IGSF1 KAT6B | 3.36e-05 | 529 | 250 | 14 | 14621295 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MAN2A1 NARS1 ACTN2 ITGAV ABCB1 ABCB4 FCGBP ALDH1L2 PLG STK24 DYNC1H1 NEDD4L FOLH1 MAN1C1 AKR7L NANS GNA13 TLN1 SNX18 HSP90AB2P CDH11 | 3.54e-05 | 1070 | 250 | 21 | 23533145 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | RDH13 TRRAP PTPN1 RBM25 SCML2 DDX18 DYNC1H1 NSD1 NOL9 SUPT16H SNX18 TTC17 RPL3 EPB41L2 | 3.64e-05 | 533 | 250 | 14 | 30554943 |
| Pubmed | MYH7 DDX1 CAPN8 TARS1 DYNC1H1 AGAP3 ARFGAP2 TLN1 EIF4G2 KIF4B HSP90AB2P KAT6B PCCA RPL3 | 4.03e-05 | 538 | 250 | 14 | 28524877 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLG1 WASF1 DYNC1H1 AGAP1 CUL3 DMXL2 NRCAM GNA13 APPL1 EPB41L2 | 4.04e-05 | 281 | 250 | 10 | 28706196 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | KIF4A SCML2 DDX50 ZNF638 SFPQ APEX1 HAT1 SUPT16H ZFHX3 TAF15 | 4.29e-05 | 283 | 250 | 10 | 30585729 |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 4.29e-05 | 283 | 250 | 10 | 28533407 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B NARS1 RABGAP1 DDX1 RBM25 NDC80 DLD HSPA2 DYNC1H1 DNAH3 SFPQ HAT1 IGF2BP1 UBE2T TLN1 HSP90AB2P RPL3 EPB41L2 | 4.75e-05 | 847 | 250 | 18 | 35235311 |
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 10488067 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 5.15e-05 | 2 | 250 | 2 | 36482480 | |
| Pubmed | A member of a family of sulfate-activating enzymes causes murine brachymorphism. | 5.15e-05 | 2 | 250 | 2 | 9671738 | |
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 5.15e-05 | 2 | 250 | 2 | 21705081 | |
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 5.15e-05 | 2 | 250 | 2 | 9196326 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 5.15e-05 | 2 | 250 | 2 | 7705657 | |
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 23041318 | ||
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 6216475 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 5.15e-05 | 2 | 250 | 2 | 30081192 | |
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 5.15e-05 | 2 | 250 | 2 | 15456492 | |
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 8898203 | ||
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 23702659 | ||
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 3678603 | ||
| Pubmed | Man to mouse--lessons learned from the distal end of the human X chromosome. | 5.15e-05 | 2 | 250 | 2 | 9414316 | |
| Pubmed | Profiles of PrKX expression in developmental mouse embryo and human tissues. | 5.15e-05 | 2 | 250 | 2 | 15879576 | |
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 2473069 | ||
| Pubmed | 5.15e-05 | 2 | 250 | 2 | 19185004 | ||
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 5.15e-05 | 2 | 250 | 2 | 22079981 | |
| Cytoband | 6q26 | 1.23e-04 | 18 | 250 | 3 | 6q26 | |
| GeneFamily | ATP binding cassette subfamily B | 1.46e-04 | 11 | 178 | 3 | 806 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 5.76e-04 | 17 | 178 | 3 | 1291 | |
| GeneFamily | DEAD-box helicases | 7.59e-04 | 42 | 178 | 4 | 499 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 8.10e-04 | 19 | 178 | 3 | 132 | |
| GeneFamily | Protein disulfide isomerases | 1.10e-03 | 21 | 178 | 3 | 692 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | PSD KIF4A NDC80 CHRDL1 NRCAM RBL1 POLE PIK3R3 REEP3 RLBP1 UBE2T TRIM62 SNX18 KIF4B | 1.66e-07 | 257 | 246 | 14 | MM1231 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MARK1 PTPN1 PAN2 PKP2 AFF1 ANKMY2 HECTD1 MTUS2 FKBP5 DYNC1H1 AGTPBP1 DMXL2 AKT3 SLC11A2 NRCAM SPOPL MAN1C1 HECTD4 GRIA4 PAPSS2 GNA13 APPL1 DDX3Y RORA IGSF1 KAT6B RPL3 | 3.16e-07 | 946 | 246 | 27 | M39169 |
| Coexpression | GSE37301_PRO_BCELL_VS_CD4_TCELL_UP | PTPN1 SMYD4 SLC9A7 TTC13 SLC11A2 RBL1 ACAD10 LCK MEMO1 HIVEP3 PUS7L | 6.62e-07 | 170 | 246 | 11 | M8893 |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | PSD KIF4A NDC80 CHRDL1 NRCAM RBL1 POLE PIK3R3 REEP3 RLBP1 UBE2T TRIM62 SNX18 | 7.45e-07 | 249 | 246 | 13 | M1796 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | IFT172 HMGCS2 ABHD17C S100P FCGBP ANKMY2 TTC13 PLEKHH2 STK24 AGAP1 DMXL2 SLC11A2 ZNF875 PIK3R3 TBC1D8 RMDN3 PDIA6 NANS CLMN SNX18 RORA SLC4A11 | 1.59e-06 | 726 | 246 | 22 | M4210 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 RABGAP1 TRRAP SLIT2 PTPN1 NDC80 ZNF638 AFF1 DLG1 ANKMY2 SPOP WASF1 STK24 AGAP1 DMXL2 SLC11A2 HAT1 FNDC3A TBC1D31 ZFHX3 TAF15 KAT6B PCCA | 6.71e-06 | 856 | 246 | 23 | M4500 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.83e-05 | 197 | 246 | 10 | M5210 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | GARS1 KIF4A RABGAP1 NDC80 DDX18 RECQL5 SFPQ RBL1 PIK3R3 ASH2L ARFGAP2 PDIA6 TBC1D31 NANS LPCAT3 DDX3Y TAF15 RPL3 EPB41L2 | 2.06e-05 | 669 | 246 | 19 | M18635 |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | 2.09e-05 | 200 | 246 | 10 | M3236 | |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_DN | 3.84e-05 | 133 | 246 | 8 | M6767 | |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_UP | 4.42e-05 | 8 | 246 | 3 | M12825 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | MAN2A1 RABGAP1 PTPN1 SCML2 ZNF638 DLD AFF1 WASF1 FKBP5 SLC11A2 PIK3R3 ASH2L LPCAT3 TGDS DDX3Y | 5.50e-05 | 481 | 246 | 15 | M3898 |
| Coexpression | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP | 9.33e-05 | 10 | 246 | 3 | M13976 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 9.71e-05 | 240 | 246 | 10 | M39236 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.17e-04 | 199 | 246 | 9 | M5893 | |
| Coexpression | GSE17721_LPS_VS_CPG_8H_BMDC_UP | 1.21e-04 | 200 | 246 | 9 | M4003 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 1.21e-04 | 200 | 246 | 9 | M6617 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | MAN2A1 SLIT2 DDX50 HECTD1 AGAP1 FNDC3A GTF2IRD1 MEMO1 SUPT16H | 1.21e-04 | 200 | 246 | 9 | M6484 |
| Coexpression | GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN | 1.21e-04 | 200 | 246 | 9 | M4114 | |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.23e-04 | 157 | 246 | 8 | M6871 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | BACH2 PDE10A SLIT2 FKBP5 AKT3 LAMA2 COL5A3 NCOA7 RORA ZFHX3 EPB41L2 | 1.26e-08 | 192 | 250 | 11 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MARK1 ASPN BACH2 SLIT2 PLEKHH2 AKT3 NRCAM LAMA2 COL5A3 TENM4 CDH11 | 1.65e-08 | 197 | 250 | 11 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | ASPN SLIT2 PLEKHH2 MMP19 LAMA2 ITGA8 TDO2 HIVEP3 TENM4 RORA CDH11 | 1.65e-08 | 197 | 250 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ACTN2 SLIT2 PLEKHH2 NRCAM ITGA8 TDO2 PAPSS2 PREX2 PLXNA4 CDH11 EPB41L2 | 1.93e-08 | 200 | 250 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | ASPN HMGCS2 RETSAT ARMC2 SLC27A6 COL5A3 HIVEP3 EVA1C TENM4 ZSCAN22 | 4.57e-08 | 170 | 250 | 10 | ba4ba66b624089ed50a9083176386c7941b4c7a3 |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.34e-08 | 176 | 250 | 10 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 8.68e-08 | 182 | 250 | 10 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-07 | 188 | 250 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-07 | 189 | 250 | 10 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDE10A SLIT2 PLEKHH2 NRCAM ITGA8 TDO2 IGDCC4 HIVEP3 PLXNA4 CDH11 | 1.30e-07 | 190 | 250 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | PDE10A SLIT2 FKBP5 AKT3 LAMA2 COL5A3 NCOA7 RORA ZFHX3 EPB41L2 | 1.36e-07 | 191 | 250 | 10 | 70c067c54084bfb02c29bab085f4defd477194fb |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-07 | 192 | 250 | 10 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ACTN2 SLIT2 CHRDL1 PLEKHH2 LAMA2 ITGA8 HIVEP3 RORA CDH11 RNF182 | 1.58e-07 | 194 | 250 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 170 | 250 | 9 | 71e5e27c3c4e6cc8dc9b063bd51c21c049f54416 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-07 | 170 | 250 | 9 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 170 | 250 | 9 | 255bbbd00d0e17510c5a8c5faa43ed90d887a9de | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-07 | 180 | 250 | 9 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-07 | 180 | 250 | 9 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-07 | 180 | 250 | 9 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.17e-06 | 187 | 250 | 9 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.17e-06 | 187 | 250 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 188 | 250 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.28e-06 | 189 | 250 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-06 | 189 | 250 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 190 | 250 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-06 | 191 | 250 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.40e-06 | 191 | 250 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-06 | 192 | 250 | 9 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-06 | 192 | 250 | 9 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-06 | 192 | 250 | 9 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-06 | 192 | 250 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.53e-06 | 193 | 250 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-06 | 193 | 250 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-06 | 193 | 250 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 193 | 250 | 9 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.53e-06 | 193 | 250 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.59e-06 | 194 | 250 | 9 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.59e-06 | 194 | 250 | 9 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-06 | 194 | 250 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.66e-06 | 195 | 250 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.66e-06 | 195 | 250 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.81e-06 | 197 | 250 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.96e-06 | 199 | 250 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.96e-06 | 199 | 250 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 200 | 250 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.05e-06 | 200 | 250 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.05e-06 | 200 | 250 | 9 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 200 | 250 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-06 | 200 | 250 | 9 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.05e-06 | 200 | 250 | 9 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.05e-06 | 200 | 250 | 9 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.21e-06 | 164 | 250 | 8 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.25e-06 | 120 | 250 | 7 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 169 | 250 | 8 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-06 | 170 | 250 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.48e-06 | 170 | 250 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 175 | 250 | 8 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.07e-06 | 176 | 250 | 8 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.37e-06 | 177 | 250 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-06 | 179 | 250 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.34e-06 | 180 | 250 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-06 | 181 | 250 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-06 | 181 | 250 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.68e-06 | 181 | 250 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 182 | 250 | 8 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 9.41e-06 | 183 | 250 | 8 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-06 | 184 | 250 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-06 | 184 | 250 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 9.79e-06 | 184 | 250 | 8 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-06 | 184 | 250 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 185 | 250 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 185 | 250 | 8 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 185 | 250 | 8 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 186 | 250 | 8 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 186 | 250 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 186 | 250 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.10e-05 | 187 | 250 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 187 | 250 | 8 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 188 | 250 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 189 | 250 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 189 | 250 | 8 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.19e-05 | 189 | 250 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.24e-05 | 190 | 250 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.24e-05 | 190 | 250 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 190 | 250 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 190 | 250 | 8 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 191 | 250 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.28e-05 | 191 | 250 | 8 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.33e-05 | 192 | 250 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 192 | 250 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-05 | 193 | 250 | 8 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.38e-05 | 193 | 250 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.38e-05 | 193 | 250 | 8 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-05 | 193 | 250 | 8 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-05 | 193 | 250 | 8 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 194 | 250 | 8 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 194 | 250 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.44e-05 | 194 | 250 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 194 | 250 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.44e-05 | 194 | 250 | 8 | 749dd8113ef260e00facac09de9861d61725124a | |
| Drug | alpha-ketoisovalerate | 5.51e-06 | 89 | 246 | 8 | CID000000049 | |
| Drug | glutathione reduced | ACO2 ITGAV ABCB1 ABCB4 PTPN1 DLD MMP19 DYNC1H1 ABCB5 APEX1 XDH CHST1 TDO2 PAPSS2 PAPSS1 P4HB LPA APPL1 AP4M1 | 6.19e-06 | 534 | 246 | 19 | CID000000745 |
| Drug | tariquidar | 9.40e-06 | 27 | 246 | 5 | CID000148201 | |
| Drug | selenide | 1.13e-05 | 28 | 246 | 5 | CID000000533 | |
| Drug | N-methylhomoveratrylamine | 1.23e-05 | 5 | 246 | 3 | CID000077039 | |
| Drug | Sdz 280 446 | 1.23e-05 | 5 | 246 | 3 | CID000164287 | |
| Drug | AC1L2MCS | 1.23e-05 | 5 | 246 | 3 | CID000023441 | |
| Drug | purine-2,6-dione | 1.91e-05 | 31 | 246 | 5 | CID005274271 | |
| Drug | AC1LA467 | 2.43e-05 | 6 | 246 | 3 | CID000461395 | |
| Drug | AC1L99H3 | 2.43e-05 | 6 | 246 | 3 | CID000440540 | |
| Drug | v 104 | 2.43e-05 | 6 | 246 | 3 | CID000107262 | |
| Disease | Colorectal Carcinoma | ABCA13 OBSCN EML2 ABCB1 ABCB4 PAN2 AGTPBP1 AMPD1 DNAH3 SLC11A2 NRCAM FOLH1 POLE ABCB5 HAT1 PREX2 HIVEP3 RHPN2 CCNB3 RNF182 | 1.85e-06 | 702 | 244 | 20 | C0009402 |
| Disease | cystic fibrosis (implicated_via_orthology) | 4.52e-05 | 9 | 244 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | human immunodeficiency virus infectious disease (implicated_via_orthology) | 6.81e-05 | 2 | 244 | 2 | DOID:526 (implicated_via_orthology) | |
| Disease | Mainzer-Saldino Disease | 6.81e-05 | 2 | 244 | 2 | C1849437 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 7.70e-05 | 53 | 244 | 5 | EFO_0022286 | |
| Disease | heart failure | 1.62e-04 | 185 | 244 | 8 | EFO_0003144 | |
| Disease | atrial fibrillation | MYH7 ABHD17C PKP2 HERC1 SLC27A6 CASQ2 ACAD10 REEP3 TMEM273 ZFHX3 PCCA | 2.88e-04 | 371 | 244 | 11 | EFO_0000275 |
| Disease | Paroxysmal atrial fibrillation | 3.32e-04 | 156 | 244 | 7 | C0235480 | |
| Disease | familial atrial fibrillation | 3.32e-04 | 156 | 244 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.32e-04 | 156 | 244 | 7 | C2585653 | |
| Disease | Autistic Disorder | 3.47e-04 | 261 | 244 | 9 | C0004352 | |
| Disease | juvenile idiopathic arthritis | 3.76e-04 | 74 | 244 | 5 | EFO_0002609 | |
| Disease | Atrial Fibrillation | 3.87e-04 | 160 | 244 | 7 | C0004238 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.00e-04 | 75 | 244 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Severe intellectual disability and progressive spastic paraplegia | 4.04e-04 | 4 | 244 | 2 | C4755264 | |
| Disease | aspartate aminotransferase measurement | KIF21B OBSCN RABGAP1 PXK ABCB1 ABCB4 WWC2 ZNF638 HEPHL1 MOS AGAP1 SMG6 NEDD4L HECTD4 NSD1 XDH TBC1D8 RORA | 5.71e-04 | 904 | 244 | 18 | EFO_0004736 |
| Disease | neuroimaging measurement | KIF21B EML2 BCR SLIT2 PTPN1 AFF1 AGAP1 SMG6 AGAP3 AKT3 SLC27A6 LAMA2 METTL4 TMEM273 IGF2BP1 RHPN2 GNA13 RORA PCCA CDH11 | 6.22e-04 | 1069 | 244 | 20 | EFO_0004346 |
| Disease | cannabis dependence measurement | 6.67e-04 | 48 | 244 | 4 | EFO_0008457 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 6.70e-04 | 5 | 244 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | plasma plasminogen measurement | 6.70e-04 | 5 | 244 | 2 | EFO_0006309 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 6.70e-04 | 5 | 244 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | Cardiomyopathies | 7.63e-04 | 130 | 244 | 6 | C0878544 | |
| Disease | Stomach Neoplasms | 8.74e-04 | 297 | 244 | 9 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 9.38e-04 | 300 | 244 | 9 | C0024623 | |
| Disease | angiostatin measurement | 9.99e-04 | 6 | 244 | 2 | EFO_0008024 | |
| Disease | Schizophrenia | PI4K2B PSD ABCA13 CMYA5 TRRAP ABCB1 PTPN1 NUFIP2 DLG1 PLG FOLH1 LAMA2 ITGA8 GRIA4 TDO2 NCS1 TENM4 | 1.17e-03 | 883 | 244 | 17 | C0036341 |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.39e-03 | 7 | 244 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | Psychotic Disorders | 1.54e-03 | 101 | 244 | 5 | C0033975 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.85e-03 | 63 | 244 | 4 | EFO_0022283 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.91e-03 | 106 | 244 | 5 | EFO_0008317, EFO_0008596 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.92e-03 | 30 | 244 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, unipolar depression | 1.92e-03 | 30 | 244 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | Epileptic encephalopathy | 1.92e-03 | 30 | 244 | 3 | C0543888 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.07e-03 | 108 | 244 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.16e-03 | 109 | 244 | 5 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.25e-03 | 110 | 244 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.25e-03 | 110 | 244 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Colorectal Neoplasms | 2.26e-03 | 277 | 244 | 8 | C0009404 | |
| Disease | coffee consumption | 2.32e-03 | 32 | 244 | 3 | EFO_0004330 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 2.33e-03 | 67 | 244 | 4 | EFO_0022245 | |
| Disease | gallbladder neoplasm | 2.36e-03 | 9 | 244 | 2 | EFO_0004606 | |
| Disease | Cataract microcornea syndrome | 2.36e-03 | 9 | 244 | 2 | C1861829 | |
| Disease | epilepsy (implicated_via_orthology) | 2.43e-03 | 163 | 244 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 2.58e-03 | 165 | 244 | 6 | C0235874 | |
| Disease | Nonorganic psychosis | 2.59e-03 | 69 | 244 | 4 | C0349204 | |
| Disease | periodontitis | 2.66e-03 | 223 | 244 | 7 | EFO_0000649 | |
| Disease | carbohydrate intake measurement | 2.77e-03 | 34 | 244 | 3 | EFO_0010811 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.93e-03 | 10 | 244 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 2.93e-03 | 10 | 244 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.93e-03 | 10 | 244 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | indoleacetate measurement | 2.93e-03 | 10 | 244 | 2 | EFO_0021015 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.18e-03 | 293 | 244 | 8 | C1708349 | |
| Disease | Burkitt Lymphoma | 3.26e-03 | 36 | 244 | 3 | C0006413 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.26e-03 | 36 | 244 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 3.53e-03 | 37 | 244 | 3 | EFO_0022252 | |
| Disease | Jeune thoracic dystrophy | 3.57e-03 | 11 | 244 | 2 | C0265275 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 3.57e-03 | 11 | 244 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.89e-03 | 239 | 244 | 7 | EFO_0010934 | |
| Disease | serum gamma-glutamyl transferase measurement | IFT172 NARS1 WWC2 RBM25 SLC9A7 AFF1 FKBP5 NEDD4L PIK3R3 HECTD4 TBC1D8 EVA1C TENM4 RHPN2 TLN1 RORA | 4.11e-03 | 914 | 244 | 16 | EFO_0004532 |
| Disease | cortical surface area measurement | EML2 RETSAT BCR SLIT2 PTPN1 AFF1 AGAP1 SMG6 AGAP3 AKT3 SLC27A6 LAMA2 SYT2 REEP3 TMEM273 IGF2BP1 TREH RORA ZFHX3 PCCA CDH11 | 4.12e-03 | 1345 | 244 | 21 | EFO_0010736 |
| Disease | Major Depressive Disorder | 4.25e-03 | 243 | 244 | 7 | C1269683 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 4.26e-03 | 12 | 244 | 2 | EFO_0800573 | |
| Disease | progression free survival, urinary bladder cancer | 4.26e-03 | 12 | 244 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | Intellectual Disability | KIF4A TRRAP WASF1 DYNC1H1 NSD1 AP4E1 SUPT16H RORA AP4M1 ALG13 | 4.29e-03 | 447 | 244 | 10 | C3714756 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 4.40e-03 | 40 | 244 | 3 | EFO_0004746 | |
| Disease | left ventricular ejection fraction measurement | 4.40e-03 | 40 | 244 | 3 | EFO_0008373 | |
| Disease | X-11444 measurement | 5.00e-03 | 13 | 244 | 2 | EFO_0021237 | |
| Disease | cataract (biomarker_via_orthology) | 5.00e-03 | 13 | 244 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 5.00e-03 | 13 | 244 | 2 | C0036996 | |
| Disease | suicide behaviour measurement | 5.40e-03 | 43 | 244 | 3 | EFO_0006882 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 5.40e-03 | 43 | 244 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | HMGCS2 PDE10A ABCB4 SLIT2 ALDH1L2 RIC1 FOLH1 PIK3R3 PAPSS2 PDIA6 MROH1 CLMN TREH NCOA7 RORA ZFHX3 | 5.63e-03 | 945 | 244 | 16 | EFO_0005653 |
| Disease | Malformations of Cortical Development | 5.80e-03 | 14 | 244 | 2 | C1955869 | |
| Disease | Saldino-Noonan Syndrome | 5.80e-03 | 14 | 244 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 5.80e-03 | 14 | 244 | 2 | C0024507 | |
| Disease | Cortical Dysplasia | 5.80e-03 | 14 | 244 | 2 | C0431380 | |
| Disease | Left ventricular noncompaction | 5.80e-03 | 14 | 244 | 2 | C1960469 | |
| Disease | thyroid peroxidase antibody measurement, anti-thyroglobulin antibody measurement | 6.14e-03 | 45 | 244 | 3 | EFO_0005666, EFO_0009896 | |
| Disease | cholelithiasis | 6.18e-03 | 88 | 244 | 4 | EFO_0004799 | |
| Disease | brain measurement, neuroimaging measurement | KIF21B RABGAP1 SLIT2 SMG6 AKT3 SLC27A6 TMEM273 RHPN2 GNA13 RORA ZFHX3 | 6.40e-03 | 550 | 244 | 11 | EFO_0004346, EFO_0004464 |
| Disease | hepatoblastoma (is_marker_for) | 6.66e-03 | 15 | 244 | 2 | DOID:687 (is_marker_for) | |
| Disease | response to statin, LDL cholesterol change measurement | 6.66e-03 | 15 | 244 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Myopia | 6.66e-03 | 15 | 244 | 2 | C0027092 | |
| Disease | Cardiomyopathy | 6.93e-03 | 47 | 244 | 3 | cv:C0878544 | |
| Disease | cancer (implicated_via_orthology) | 7.17e-03 | 268 | 244 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | respiratory system disease | 7.25e-03 | 145 | 244 | 5 | EFO_0000684 | |
| Disease | triglyceride measurement, phospholipid measurement | 7.46e-03 | 146 | 244 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | response to triptolide, cytotoxicity measurement | 7.57e-03 | 16 | 244 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | Intrahepatic cholestasis of pregnancy | 7.57e-03 | 16 | 244 | 2 | EFO_0009048 | |
| Disease | central nervous system disease (implicated_via_orthology) | 7.57e-03 | 16 | 244 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Cannabis use | 7.57e-03 | 16 | 244 | 2 | EFO_0007585 | |
| Disease | cholestasis (biomarker_via_orthology) | 7.78e-03 | 49 | 244 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 8.07e-03 | 95 | 244 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFNPETDYLTGTDGK | 506 | Q99798 | |
| YVQEESPEGGRFKKE | 116 | Q96P47 | |
| QEEPLLAFKGGKYVS | 1141 | Q86US8 | |
| KDNFLGLRGKSDPYA | 321 | A0FGR9 | |
| DPEGKGFLDKQGFYV | 61 | Q9UBC2 | |
| LLGFKAKGDYLPETT | 591 | Q9HCE0 | |
| PFDKGITQGDLKTDY | 371 | Q9BYV9 | |
| LEKGDYKDSSDFGAP | 166 | P43320 | |
| DLIDYSKLNKDDPIG | 196 | P35609 | |
| EGSFEKYLERLGDPK | 281 | Q9NP73 | |
| KYLERLGDPKESAGQ | 286 | Q9NP73 | |
| YVQEESPEGGRFKKE | 96 | Q9UPQ3 | |
| YEDKDGKQPVGRFFG | 211 | Q8NHP1 | |
| SELKDGAYLDNPPKG | 106 | Q8IX95 | |
| FSDNALPYKTGKKGD | 466 | Q9P2K8 | |
| KEDDESPGLYGFLNV | 901 | P11274 | |
| FGFPSLYEESKGKET | 76 | Q9Y2D8 | |
| GYKPESIEGTVEFKN | 376 | Q2M3G0 | |
| FGKDLGEEALNEYLK | 901 | Q3SY69 | |
| LDGSFDPDLKNYHKL | 821 | Q8NEN0 | |
| DYDKTKDSGLPSQGL | 591 | Q12959 | |
| DPYVAKLANISGKDD | 256 | A7E2U8 | |
| PGKNITEGLKDVYSF | 1761 | Q86UQ4 | |
| EADPEKKYGAGLTNV | 721 | Q6JQN1 | |
| DDVGTFASGPPKYKD | 346 | Q8N6H7 | |
| EKVKFLGDNYLEEGP | 696 | P23109 | |
| DFTGGISEFYDLKKP | 206 | A6NHC0 | |
| GAAKVLLDTFEYPGL | 116 | A0A0U1RR11 | |
| KRKQSEVEADLGYPG | 2636 | Q8TDJ6 | |
| KKNDKEAAGEGPALY | 31 | P27695 | |
| QKYVDPLAGAADGKE | 431 | Q9UPS8 | |
| YTIPEEGDILKFNSK | 701 | Q9UPW5 | |
| EIKENDFKGLTSLYG | 116 | Q9BXN1 | |
| GSTYAPEGEVLKNDK | 386 | O14983 | |
| TDGSFIGYKEKPQDV | 31 | Q9Y243 | |
| EKDFKDYVNLGPLGV | 356 | Q8IWF9 | |
| EGYPSIAEGETLFKK | 786 | Q8WWL7 | |
| KGDPLIYKDFRGDSG | 11 | O00189 | |
| GKIAELAEKYAPDNA | 431 | Q9UPM8 | |
| YPKFGLLDQDLSNIG | 251 | Q9UBL3 | |
| EDILIGGLKPFTKYE | 806 | Q8TDY8 | |
| GGDLKPSANLYEKFK | 686 | Q5JR59 | |
| INLYTDKDTGKPKGE | 271 | Q92804 | |
| KLVPLDYGEDDKNAT | 711 | P49756 | |
| LDKDRIIDAGPKGNY | 2001 | Q96L73 | |
| KEEGYGEAAQFDGLK | 506 | Q9ULC6 | |
| GDFAYRSDGTKKDPL | 346 | Q4ADV7 | |
| ASDPDEGINGKVAYK | 266 | Q9Y5G5 | |
| FANYAGADAPIEKGK | 621 | P12883 | |
| EYFSLVEKDNPDGGK | 176 | Q9Y5F8 | |
| LKDGYEKVEQDLPAF | 116 | Q7Z4N8 | |
| KGLASYKDPDNPGRF | 66 | Q8WYB5 | |
| FYDPLAGKVLLDGKE | 1086 | P08183 | |
| TAYGKELPGFLAPEK | 96 | Q9H790 | |
| DDGKGYFSAVPKDKD | 301 | Q9Y3P9 | |
| DKALGLDSANEKGLY | 341 | Q13451 | |
| DYNFKLPGASEKIGA | 666 | Q5SY16 | |
| QYSGIKPGDLDAKIS | 1041 | Q504Q3 | |
| EIKGFTGIDSDYEKP | 171 | O95340 | |
| IKEEKGSPLNAAPYG | 346 | P18031 | |
| LLQGKALFPGSDYID | 216 | Q15759 | |
| QKLGPGSYNLKDFLE | 121 | Q3ZCV2 | |
| YKGFIKDCPSGQLDA | 31 | P62166 | |
| PDLEKAAAFYKNILG | 56 | Q96PE7 | |
| KRDKSGAYLFLPDGN | 801 | Q16706 | |
| IYPKSTGNKGFEDGD | 116 | Q9NQ76 | |
| SFIGQYSGKKEKEPA | 1271 | Q92823 | |
| YSGKKEKEPAEGNES | 1276 | Q92823 | |
| RVYAGAPKKAEGADL | 276 | Q8WXT5 | |
| EPIDGYQLKEFDGKS | 291 | Q58FF8 | |
| YGKLKEENFFGPKEE | 471 | Q9NZI8 | |
| KEYEKQRFPLGGDDE | 66 | Q9UKG1 | |
| LKSPDEGFEGKSLYE | 481 | Q04609 | |
| YFDGKLLLGTKEPLE | 3601 | Q15751 | |
| PKDGFVALSKAPDGY | 251 | Q92499 | |
| KDYFGLLFQESPEQK | 256 | O43491 | |
| EAFGGLKLEDTYTNK | 336 | P54868 | |
| IVPDGKYGARDADTK | 466 | P48058 | |
| LEKTDEPGKYTANRG | 86 | Q5VSP4 | |
| EPTAAAIAYGLDKKG | 176 | P54652 | |
| DKLFIATAVDGKPEY | 181 | Q9HCM2 | |
| FIKDSGDKGSPFLNI | 101 | Q9Y664 | |
| DDVAGIQALYGKKSP | 246 | Q99542 | |
| RDKKDEVPQGQLGFY | 706 | Q9Y233 | |
| LYVDDPDKDSGGKID | 56 | Q969X5 | |
| GEPQVLLGKDKAFTY | 36 | O75037 | |
| ALEGVKPEKLDAFYS | 276 | Q6ZR08 | |
| KLIGLAVDYFDGGKD | 151 | Q6P1A2 | |
| YNTRLFKEVDGEGKP | 196 | Q9NY33 | |
| DNEYTAREGAKFPIK | 391 | P06239 | |
| PKDNSTLAVDIYKGG | 346 | P49281 | |
| DLKADDKIYFGGLPT | 2461 | P24043 | |
| VKEGYEKADPAQFEL | 61 | Q9UK32 | |
| EIGFQKDSQGEYKAP | 386 | Q07864 | |
| AAAKAKLGYDPVELD | 426 | Q07864 | |
| PEYAKAAGKLKAEGS | 61 | P07237 | |
| GESVKYFLDNLDKLG | 171 | Q14344 | |
| SKLENGGFPYEKDLI | 76 | Q9BRT3 | |
| LGSVGYDPNEKTFDK | 51 | P05165 | |
| KEPLYVGVDDDKANA | 381 | Q9NVP1 | |
| GSPGLEDYFNDKSIK | 3226 | Q9Y4D8 | |
| PKEEDGGCQKSLYLE | 881 | Q8NDA8 | |
| EDITQEFPGKGKALF | 871 | P78344 | |
| DKNDYPDLIVGAFGT | 461 | P53708 | |
| SDNGKNEPLEKSGYL | 696 | Q8IVE3 | |
| KYFDGLKQKAPAPEA | 286 | Q8NBN7 | |
| LPVDKAFYEAGIAAK | 1571 | Q9UG01 | |
| LIDSYSEEGLKPDKF | 1016 | P21439 | |
| KDGVQLGPSDKYDFL | 2681 | Q5VST9 | |
| PKIGSFQLFVEGYKE | 251 | Q8TCG2 | |
| SDKIPKAKDTQGFYG | 1196 | Q460N5 | |
| EIKGFTGIDSEYEKP | 181 | O43252 | |
| VQAEDLLYGKPDGAF | 366 | Q92569 | |
| APFDKDNYKELLGGV | 76 | Q8TED4 | |
| KPSLKQKDGEYGINF | 276 | P58658 | |
| AEGKFDLKLAPGYDP | 1326 | Q9ULT8 | |
| PVDGVGLALYKKGED | 346 | Q8N6C5 | |
| GDDETAFGYKGLKIL | 61 | O14929 | |
| GAAKVLLDTFEYPGL | 116 | P0DPI3 | |
| KAKELPGQSFDNKGY | 326 | Q9BU40 | |
| PEDGAYIKGLFLEGA | 4011 | Q8TD57 | |
| DKGGSPYVAAKINEA | 126 | Q9Y5T4 | |
| YNQDPADDLKAVGGK | 4616 | Q9Y6R7 | |
| LGEKDYPILFKNGTL | 201 | Q5T0N1 | |
| LGKDSEFKQIYKGPD | 1086 | Q9Y2H6 | |
| ATFYGPVKKEDGSEV | 561 | Q13618 | |
| GLEEKRVGKDDSYQP | 3261 | Q8N3K9 | |
| NDIAIAAPYGGEDKK | 386 | P06756 | |
| DSDQKKIYIGDDNPL | 641 | P06756 | |
| GAAKVLLDTFEYPGL | 116 | A0A0U1RRI6 | |
| IPDLASEFKEGAYKD | 126 | Q9HC77 | |
| NSGLASEKDYPFQGK | 206 | P56202 | |
| KTFGPVYEGKDLIAQ | 166 | Q9BQ39 | |
| KAKDPDIGENGLVTY | 291 | P55287 | |
| PDDGELKELYGLYKQ | 21 | Q8N6N7 | |
| GKPSEKNLYADIDAA | 176 | Q6PCB6 | |
| LKGRASDGFPVYQEK | 251 | Q8IV38 | |
| GGPLVCFEKDKYILQ | 1991 | P08519 | |
| LGKKGELSDDYPSLQ | 116 | P53673 | |
| EEGIEYKVGKFPFAA | 411 | P09622 | |
| SNERPGKEQLYFFGK | 1091 | Q6MZM0 | |
| KNELRPLTKDGYEGN | 196 | Q9NR34 | |
| ELFQGKKYDGPEVDV | 226 | Q9P0L2 | |
| GPEFKKLAELYGEIE | 771 | Q13634 | |
| AYAGAPKKAEGADLA | 276 | Q9NU39 | |
| KLKGTVGEPTYDAEF | 3891 | Q14204 | |
| ALGDDKKGGFVPYRD | 276 | O95239 | |
| ALGDDKKGSFVPYRD | 276 | Q2VIQ3 | |
| KSDPDGYEFLEILKQ | 276 | O14958 | |
| KPKYVLCVTFLEGGD | 251 | O95834 | |
| RSTFKPEEGKEAGYA | 636 | Q96PD2 | |
| LPGVGELLETYKDKF | 266 | Q9H069 | |
| YTDGPGEALKAVKEN | 241 | O15523 | |
| VKELFNEKYGEALGL | 806 | Q9UHL9 | |
| KAELGSQEGYVPKNF | 36 | O75791 | |
| YSVTGLDEVPFKGEK | 336 | P20807 | |
| YILSPDEKFGFEKGE | 311 | Q96RY7 | |
| GGETCLYPDKKFEIV | 1581 | P25940 | |
| YVLAGEVAKDKAGPS | 51 | Q8WY07 | |
| KSGFLYPLFEKQDKG | 171 | Q8N3J2 | |
| KIFQKGESPVDYDGG | 241 | Q15084 | |
| NDNGDLLPFKKGAFY | 176 | O15120 | |
| ENKNFTLGEYKFGPL | 121 | Q8WV60 | |
| DKYLFTILAKDNGVP | 566 | Q9BZA8 | |
| EQEFGKLFSKYLADP | 166 | Q9Y316 | |
| LKGEGVTPKADIYSF | 251 | P00540 | |
| SGEKAYIQGLKEKFP | 171 | Q6NUM9 | |
| KAYLPQELLGKEGFD | 321 | P51398 | |
| ETFTFKVPYQELGGK | 206 | Q8N9I0 | |
| DGAFYGPKIDIQIKD | 536 | P26639 | |
| FVGLYCDKKLIAEGP | 271 | Q9H9J2 | |
| FLKAEELQPGFSKAG | 406 | Q96TC7 | |
| YPLDFTDGIIGKNKA | 341 | Q8NBS3 | |
| SKGYLVGKDSDAPLF | 56 | Q8IYR2 | |
| TGDFESKKNELPDGL | 396 | Q96DN5 | |
| NDGGDFPRELLKALY | 686 | A5PKW4 | |
| KKEDGTFYEFGEDIP | 406 | O43776 | |
| FGYTFKKLPVEGSEE | 11 | P48775 | |
| SPDVYGKDAKEQGFV | 711 | Q8NI08 | |
| LEKTFEQTKYLAGPE | 251 | P78426 | |
| GPVKEERGDLIKFYN | 921 | P28749 | |
| GVIPSDFSYAGLKDK | 326 | Q9H0K6 | |
| DYDLSDKSINPLGGF | 306 | P39023 | |
| LEGNYSKPLKEFVEA | 251 | Q9Y6E0 | |
| GFEYILAKLQGEAPS | 161 | Q9Y255 | |
| DDNPFGIYQKILAGK | 246 | O43930 | |
| ARYPLFEGQETGKKE | 721 | P41250 | |
| SDLEAGKQLPFIYGD | 51 | Q15858 | |
| KVGSGDTNNFPYLEK | 131 | Q9NR45 | |
| KCLYKIIDFGDSPQG | 46 | Q8N6D2 | |
| SPDFSKDEDYLGKVG | 926 | Q9Y6Y8 | |
| GGPLVCFEKDKYILQ | 761 | P00747 | |
| GKKPEEKTYALFIGD | 391 | Q9Y5B9 | |
| ESAGYGIPLKDGDEK | 186 | Q6NUK4 | |
| QPLEKENDGYFRKGC | 11 | Q8IUC4 | |
| FKDKSRVDLDGLYDP | 1626 | O60287 | |
| FGEPYKTAKGDELSS | 41 | P51825 | |
| EEGDYFEAIPLKASK | 551 | Q96JQ2 | |
| KKTEEIYGFLGIPLD | 311 | O43916 | |
| PDFIAGKKLAEYGPQ | 136 | A8K7I4 | |
| FKELISDPYGNLKDF | 231 | O94762 | |
| LFAKYGEPGEVFINK | 316 | P23246 | |
| YGGSLDKEFDESSPK | 146 | O95455 | |
| GSAPQQDYDKLKALG | 166 | Q9HCE3 | |
| GDYIEKPDFALKSIG | 191 | Q8TC36 | |
| KVPSLKDQGKEYDGF | 676 | Q8NBP0 | |
| LDFLLQEKSGYIPSG | 486 | Q6AWC2 | |
| QGLETFKPDYSEQKG | 256 | Q7Z417 | |
| FKPDYSEQKGNRVDG | 261 | Q7Z417 | |
| PEALAKIIDEGGYTK | 166 | Q96MW7 | |
| FDGKYASPDVFKSLG | 381 | P35398 | |
| KTKEYASEGEPLFAG | 516 | Q9UQR0 | |
| DTFKEYDPDGKGIIS | 3926 | Q15413 | |
| YDPDGKGIISKKEFQ | 3931 | Q15413 | |
| DFGLFLSDDDPKKGI | 46 | Q9Y490 | |
| VNPKGLDDESKDYLS | 71 | Q6IQ16 | |
| VNPKGLDEESKDYLS | 71 | O43791 | |
| FVKDGDKLCVVLGPY | 251 | Q96RF0 | |
| LVFGKPNGDAVDYQK | 951 | O95759 | |
| FSDPGVADKALKYLE | 426 | O43280 | |
| EPARIKIFEGGYKSN | 1726 | Q5T1R4 | |
| GANTPYEKGVFKLEV | 41 | Q9NPD8 | |
| ADLGPDKYLSDKDFQ | 181 | Q7Z7A4 | |
| GDDGYAKDAKLNTPS | 1526 | Q6N022 | |
| LPGFLQSGKDKDAVD | 41 | P25815 | |
| NSFYGPELKIEKGDL | 706 | P47989 | |
| IKSNEGSYGFGLEDK | 596 | Q70Z35 | |
| YGNKITELPKSLFEG | 356 | O94813 | |
| GTLPKYDGKAVAEQL | 291 | P12271 | |
| VDFPDGGYSLKLSKL | 81 | Q9NQ25 | |
| KAKVPLGDLDLYDGT | 116 | Q96AE7 | |
| DDNPFGIYQKILAGK | 246 | P51817 | |
| KPSKIGIFLDYELGD | 411 | Q495X7 | |
| RNPLGDKNGKDTEYI | 76 | Q9UJW7 | |
| LDLLIPKGDYGKAES | 141 | P51523 | |
| PKGDYGKAESDDFNV | 146 | P51523 | |
| KPPSEDKFDLVDAYG | 241 | P10073 | |
| FKEKYSEFSGGDDPL | 871 | P86452 | |
| GEKPALNDGSKRYFI | 646 | Q9BRH9 | |
| PEEDAKLLQAVAKYG | 406 | Q5SXM2 | |
| KYEEFGPGFIKESNL | 246 | P10072 | |
| RDDGKEGLKFYTNPS | 141 | Q92558 | |
| KSKIDLQGPEVGYFS | 126 | Q6P280 | |
| DVFKKGDVYLNTGDL | 451 | Q9Y2P4 | |
| FEYTLKGEISPGKIN | 151 | Q96T83 | |
| SYKKAPGFEREDQVG | 411 | Q9C0B0 | |
| KTPGAEIDFKYALIG | 26 | Q5T292 | |
| DKLDKVGVFLDYDQG | 411 | Q9BVG3 | |
| GLEFPIYFQGKDAAD | 61 | A0A0A6YYK4 | |
| IYFQGKDAADKSGLP | 66 | A0A0A6YYK4 | |
| GDYPKANGLLDFDIF | 541 | Q99959 | |
| ILNPAFLYSFEKGEG | 1776 | Q9Y4A5 | |
| AKDFADFGYKQGDPI | 271 | Q96GX1 | |
| DAKADPKGALADYEG | 396 | O15231 | |
| PKGALADYEGKDVAT | 401 | O15231 | |
| EVYDLAKPFGGLKDI | 921 | Q14966 | |
| EGSPLAEKDENGKYL | 91 | O95922 | |
| IGSQLDKEKEYFDPA | 3056 | Q15911 | |
| PAATGLAKGDSKYIE | 651 | Q5R3F8 | |
| DGKKLPQGESRSYEV | 156 | Q5T7N2 | |
| QKEIPFSYLVGDSGK | 506 | Q5T7N2 | |
| PKGAENSKGYDFEIK | 426 | O14777 | |
| DLAKKDIFGASDPYV | 31 | Q96PU5 |